Clinical Trial Update: EPO for Postop Delirium in Elderly Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on erythropoietin (EPO) for postoperative delirium in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Delirium

Drugs mentioned

• EPO (erythropoietin)

Snippet

Sponsor: Yonsei University | Conditions: Postoperative Delirium | Phase 4 | Status: COMPLETED